Table 3.
Correlation of time interval between sampling and delivery and β-hCG values
| β-hCG level versus duration | Control (n = 50) | Case | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group 2A (N = 50) | Group 2B (N = 50) | |||||||||||
| < 2 weeks | 2–4 weeks | 4–6 weeks | > 6 weeks | < 2 weeks | 2–4 weeks | 4–6 weeks | > 6 weeks | < 2 weeks | 2–4 weeks | 4–6 weeks | > 6 weeks | |
| < 25 mIU/mL | ||||||||||||
| No. | 0 | 0 | 8 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| % | 0.0 | 0.0 | 16.0 | 76.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 25–49 mIU/mL | ||||||||||||
| No. | 1 | 3 | 0 | 0 | 0 | 1 | 5 | 22 | 0 | 1 | 0 | 0 |
| % | 2.0 | 6.0 | 0.0 | 0.0 | 0.0 | 2.0 | 10.0 | 44.0 | 0.0 | 2.0 | 0.0 | 0.0 |
| 50–74 mIU/mL | ||||||||||||
| No. | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 1 |
| % | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 4.0 | 2.0 | 0.0 | 0.0 | 2.0 | 2.0 |
| 75–99 mIU/mL | ||||||||||||
| No. | 0 | 0 | 0 | 0 | 3 | 6 | 1 | 0 | 9 | 6 | 7 | 0 |
| % | 0.0 | 0.0 | 0.0 | 0.0 | 6.0 | 12.0 | 2.0 | 0.0 | 18.0 | 12.0 | 14.0 | 0.0 |
| 100–124 mIU/mL | ||||||||||||
| No. | 0 | 0 | 0 | 0 | 5 | 3 | 0 | 0 | 9 | 2 | 1 | 0 |
| % | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 6.0 | 0.0 | 0.0 | 18.0 | 4.0 | 2.0 | 0.0 |
| 125–149 mIU/mL | ||||||||||||
| No. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 0 | 0 |
| % | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.0 | 6.0 | 0.0 | 0.0 |
| ≥ 150 mIU/mL | ||||||||||||
| No. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | |
| % | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.0 | 0.0 | 0.0 | 0.0 |
If β-hCG level < 21.5 mIU/mL—100% patient delivered after 4 week
If β-hCG level > 75 mIU/mL—56% patients delivered within 4 weeks
The bold values signify number of patients who were delivered within the specified level of beta-hcG